DrugBiological
MP-101 clinical trials
Also written LY2979165 and MP101.
- studies test it
- 5
- open now
- 1
- in phase 3
- 0
- first study started
- 2010
Keep track of what changes. Save the MP-101 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 1
Eli Lilly and Company (3) · MicrobiotiX Co., Ltd (1) · Mediti Pharma Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses MP-101 is read from its arms, and is right about nine times in ten.
Testing it · 5
- MP101 in Adults With Acute Pseudomonas Aeruginosa PneumoniaRecruitingPhase 1MicrobiotiX Co., LtdNCT07492771Written as MP101
- A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and AggressionTerminatedPhase 2Mediti Pharma Inc.NCT03044249Written as MP-101
- A Study of LY2979165 and LY2140023 in Healthy VolunteersCompletedPhase 1Eli Lilly and CompanyNCT01524237Written as LY2979165
- A Study of LY2979165 in Healthy SubjectsCompletedPhase 1Eli Lilly and CompanyNCT01383967Written as LY2979165
- A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy VolunteersCompletedPhase 1Eli Lilly and CompanyNCT01248052Written as LY2979165